Objectives: To investigate the impact of the TCS AFO on spatial and temporal gait parameters, electromyography (EMG), and walking endurance, in select individuals with MS.
Methods: This was a non-randomized, single group (N=15), repeated measures study. The outcome measures for the study included: 1. Computerized gait analysis (GAITRite), 2. EMG of the anterior tibialis (AT), gastrocnemius (GN), and vastus lateralis (VL) muscles, 3. 6-Minute Walk Test (6MWT), and 4. 12-Item MS Walking Scale. This study was 12 weeks long consisting of 5 training sessions and 3 testing periods.
Results: Preliminary gait analysis data on four subjects indicated a trend towards improvements in absolute step length and step length symmetry, stance symmetry, and gait velocity. Endurance was also markedly increased as measured by the 6MWT. EMG analysis revealed increased AT and GN activity with the AFO on vs. off. In addition, improved timing of the AT and GN was evident with the AFO on compared to no AFO. Also notable were marked improvements in perception of walking abilities as measured by the 12-Item MS Walking Scale.
Conclusions: Results from our preliminary analysis suggested that there is marked benefit of the TCS AFO on overall gait parameters, including step length and stance symmetry, as well as endurance. Patient perception of gait impairment was also less after use of the brace for the 12-week period. In addition, the orthosis design appeared to facilitate more typical muscle firing in the leg during gait, thus providing the opportunity for halting and potentially reversing the development of secondary weakness.